skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
Sagopilone (Code C61072)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Sagopilone

Definition: A fully synthetic low-molecular-weight epothilone with potential antineoplastic activity. Sagopilone binds to tubulin and induces microtubule polymerization while stabilizing microtubules against depolymerization, which may result in the inhibition of cell division, the induction of G2/M arrest, and apoptosis. The agent is not a substrate for the P-glycoprotein (P-gp) efflux pump and so may exhibit activity in multidrug-resistant (MDR) tumors. The epothilone class of metabolites was originally isolated from the myxobacterium Solangium cellulosum.

NCI-GLOSS Definition: A form of the substance epothilone that is made in the laboratory. It is being studied in the treatment of some types of cancer. Epothilone ZK2219477 stops the growth of tumor cells by blocking cell division. It is a type of antimitotic agent.

Display Name: Sagopilone

Label: Sagopilone

NCI Thesaurus Code: C61072 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2355512  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
epothilone ZK219477
Epothilone ZK219477

External Source Codes: 
CAS Registry Number 305841-29-6 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 615854
PDQ Open Trial Search ID 615854 (check for NCI PDQ open clinical trial info)
UMLS CUI C2355512

Other Properties:
     Name Value (qualifiers indented underneath)
Chemical_Formula C30H41NO6S
code C61072
Contributing_Source CTRP
Contributing_Source FDA
Legacy_Concept_Name ZK219477
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom